Home > Insider Trading > Filing (0001209191-17-035173)

Filing Details

Accession Number:: 0001209191-17-035173
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-24 20:18:49
Reporting Period:: 2017-05-22

Filing Date:: 2017-05-24
Accepted Time:: 2017-05-24 20:18:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1560241	G1 Therapeutics Inc.	GTHX	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1208570	Jr B Kenneth Lee	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No
1219890	Alexander Robert Ingram	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No
1291262	Md Douglas Reed	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No
1592380	Clay Thorp	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No
1674107	John Crumpler	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No
1675232	Hatteras Venture Partners Iv Sbic, Lp	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No
1675236	Hatteras Venture Advisors Iv Sbic, Llc	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-05-22	3,728,464	$0.00	3,728,464	No	4	C	Indirect	By Hatteras Venture Partners IV SBIC, LP
Common Stock	Acquisiton	2017-05-22	212,419	$0.00	212,419	No	4	C	Indirect	By Hatteras NC Fund, LP
Common Stock	Acquisiton	2017-05-22	99,513	$0.00	99,513	No	4	C	Indirect	By L2 Ventures, LLC
Common Stock	Acquisiton	2017-05-22	133,333	$15.00	3,861,797	No	4	P	Indirect	By Hatteras Venture Partners IV SBIC, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Hatteras Venture Partners IV SBIC, LP
No	4	C	Indirect	By Hatteras NC Fund, LP
No	4	C	Indirect	By L2 Ventures, LLC
No	4	P	Indirect	By Hatteras Venture Partners IV SBIC, LP

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series 1 Preferred Stock	Disposition	2017-05-22	1,318,681	$0.00	439,560	$0.00
Common Stock	Series A Preferred Stock	Disposition	2017-05-22	6,568,527	$0.00	2,189,508	$0.00
Common Stock	Series B Preferred Stock	Disposition	2017-05-22	2,584,959	$0.00	861,651	$0.00
Common Stock	Series C Preferred Stock	Disposition	2017-05-22	1,009,693	$0.00	336,563	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The Preferred Stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering pursuant to the Issuer's Fifth Restated Certificate of Incorporation, as amended, based on the conversion rate in effect at the time of conversion. The Series 1 Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted to Common Stock on a 1-for-3 basis.
The reportable securities are owned directly by Hatteras Venture Partners IV SBIC, LP ("HVP IV"). Hatteras Venture Advisors IV SBIC, LLC ("HVA IV SBIC") is the general partner of HVP IV. The securities directly held by HVP IV are indirectly held by the individual managing members of HVA IV SBIC (each, a "GP Managing Member" and collectively, the "GP Managing Members"). The GP Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The GP Managing Members may share voting and dispositive power over the securities directly held by HVP IV. Each GP Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any GP Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
The reportable securities are owned directly by Hatteras NC Fund, LP ("Hatteras NC"). Hatteras Venture Advisors IV, LLC ("HVA IV") is the general partner of Hatteras NC Fund, LP. The securities directly held by Hatteras NC are indirectly held by the individual managing members of HVA IV (each, a "HVA IV Managing Member" and collectively, the "HVA IV Managing Members"). The HVA IV Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The HVA IV Managing Members may share voting and dispositive power over the securities directly held by HVP IV. Each HVA IV Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any HVA IV Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
The reportable securities are owned directly by L2 Ventures, LLC ("L2 Ventures"). Hatteras Venture Advisors V, LLC ("HVA V") is the general partner of L2 Ventures. The securities directly held by L2 Ventures are indirectly held by the individual managing members of HVA V (each, a "L2 Managing Member" and collectively, the "L2 Managing Members"). The L2 Managing Members are John Crumpler, Clay Thorp, Christy Shaffer, Douglas Reed and Robert Ingram. The L2 Managing Members may share voting and dispositive power over the securities directly held by HVA V. Each L2 Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any L2 Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
Reflects shares Hatteras Venture Partners IV SBIC, LP purchased in the initial public offering at the initial public offering price of $15.00 per share.
The Series 1 Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon consummation of the Issuer's initial public offering and had no expiration date.
Includes shares of Series A Preferred Stock convertible into 1,990,276 shares of the Issuer's common stock held by HVP IV and shares of Series A Preferred Stock convertible into 199,232 shares of the Issuer's common stock held by Hatteras NC.
Includes shares of Series B Preferred Stock convertible into 804,208 shares of the Issuer's common stock held by HVP IV and shares of Series B Preferred Stock convertible into 57,443 shares of the Issuer's common stock held by L2 Ventures, LLC.
Includes shares of Series C Preferred Stock convertible into 294,493 shares of the Issuer's common stock held by HVP IV and shares of Series C Preferred Stock convertible into 42,070 shares of the Issuer's common stock held by L2 Ventures, LLC.